Reviewed,
UniProtKB/Swiss-Prot P35575 (G6PC_HUMAN)
Last modified
July 7, 2009.
Version 90.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Glucose-6-phosphatase Short name=G-6-Pase Short name=G6Pase EC=3.1.3.9 Alternative name(s): Glucose-6-phosphatase alpha Short name=G6Pase-alpha | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 357 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Hydrolyzes glucose-6-phosphate to glucose in the endoplasmic reticulum. Forms with the glucose-6-phosphate transporter (SLC37A4/G6PT) the complex responsible for glucose production through glycogenolysis and gluconeogenesis. Hence, it is the key enzyme in homeostatic regulation of blood glucose levels. |
| Catalytic activity | D-glucose 6-phosphate + H2O = D-glucose + phosphate. |
| Pathway | |
| Subcellular location | Endoplasmic reticulum membrane; Multi-pass membrane protein. |
| Involvement in disease | Defects in G6PC are the cause of glycogen storage disease type 1A (GSD1A) [MIM:232200]; also known as von Gierke disease. GSD1A is a metabolic disorder characterized by impairment of terminal steps of glycogenolysis and gluconeogenesis. GSD1 patients manifest a wide range of clinical symptoms and biochemical abnormalities, including hypoglycemia, severe hepatomegaly due to excessive accumulation of glycogen, kidney enlargement, growth retardation, lactic acidemia, hyperlipidemia, and hyperuricemia. Ref.7 Ref.8 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 Ref.16 Ref.17 Ref.18 Ref.19 Ref.20 Ref.21 Ref.22 Ref.23 Ref.24 Ref.25 |
| Sequence similarities | Belongs to the glucose-6-phosphatase family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Gluconeogenesis |
| Cellular component | Endoplasmic reticulum Membrane |
| Coding sequence diversity | Polymorphism |
| Disease | Disease mutation Glycogen storage disease |
| Domain | Transmembrane |
| Molecular function | Hydrolase |
| PTM | Glycoprotein |
| Technical term | Complete proteome |
| Gene Ontology (GO) | |
| Biological process | gluconeogenesis Ref.1 Inferred from mutant phenotype. Source: UniProtKB glucose homeostasis Ref.1Inferred from mutant phenotype. Source: UniProtKB |
| Cellular component | integral to endoplasmic reticulum membrane Traceable author statement. Source: UniProtKB |
| Molecular function | glucose-6-phosphatase activity Ref.1 Ref.7 Inferred from direct assay. Source: UniProtKB phosphate binding Ref.5Inferred from mutant phenotype. Source: UniProtKB |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 357 | 357 | Glucose-6-phosphatase | PRO_0000087413 | |||||
Regions | |||||||||
| Topological domain | 1 – 28 | 28 | Lumenal Potential | ||||||
| Transmembrane | 29 – 49 | 21 | Potential | ||||||
| Topological domain | 50 – 60 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 61 – 81 | 21 | Potential | ||||||
| Topological domain | 82 – 117 | 36 | Lumenal Potential | ||||||
| Transmembrane | 118 – 138 | 21 | Potential | ||||||
| Topological domain | 139 – 147 | 9 | Cytoplasmic Potential | ||||||
| Transmembrane | 148 – 168 | 21 | Potential | ||||||
| Topological domain | 169 – 179 | 11 | Lumenal Potential | ||||||
| Transmembrane | 180 – 202 | 23 | Potential | ||||||
| Topological domain | 203 – 209 | 7 | Cytoplasmic Potential | ||||||
| Transmembrane | 210 – 230 | 21 | Potential | ||||||
| Topological domain | 231 – 254 | 24 | Lumenal Potential | ||||||
| Transmembrane | 255 – 275 | 21 | Potential | ||||||
| Topological domain | 276 – 291 | 16 | Cytoplasmic Potential | ||||||
| Transmembrane | 292 – 312 | 21 | Potential | ||||||
| Topological domain | 313 – 320 | 8 | Lumenal Potential | ||||||
| Transmembrane | 321 – 341 | 21 | Potential | ||||||
| Topological domain | 342 – 357 | 16 | Cytoplasmic Potential | ||||||
| Motif | 354 – 357 | 4 | Prevents secretion from ER Potential | ||||||
Sites | |||||||||
| Active site | 119 | 1 | Proton donor Potential | ||||||
| Active site | 176 | 1 | Nucleophile Ref.5 | ||||||
| Binding site | 83 | 1 | Substrate Potential | ||||||
| Binding site | 170 | 1 | Substrate Potential | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 96 | 1 | N-linked (GlcNAc...) Ref.4 | ||||||
Natural variations | |||||||||
| Natural variant | 5 | 1 | M → R in GSD1A. Ref.22 | VAR_046249 | |||||
| Natural variant | 16 | 1 | T → A in GSD1A. Ref.20 Ref.25 | VAR_046250 | |||||
| Natural variant | 16 | 1 | T → R in GSD1A; abolishes enzyme activity as well as reduces enzyme stability. Ref.20 Ref.25 | VAR_046251 | |||||
| Natural variant | 20 | 1 | Q → R in GSD1A. Ref.19 Ref.24 | VAR_009202 | |||||
| Natural variant | 38 | 1 | D → V in GSD1A. Ref.11 Ref.17 Ref.22 Ref.24 | VAR_005237 | |||||
| Natural variant | 54 | 1 | Q → P in GSD1A. Ref.16 Ref.22 Ref.25 | VAR_009203 | |||||
| Natural variant | 63 | 1 | W → R in GSD1A. Ref.17 | VAR_046252 | |||||
| Natural variant | 65 | 1 | A → P in GSD1A. Ref.24 | VAR_046253 | |||||
| Natural variant | 68 | 1 | G → R in GSD1A. Ref.13 Ref.24 | VAR_046254 | |||||
| Natural variant | 76 | 1 | K → N in GSD1A. Ref.21 | VAR_046255 | |||||
| Natural variant | 77 | 1 | W → R in GSD1A. Ref.11 Ref.21 Ref.24 | VAR_005238 | |||||
| Natural variant | 81 | 1 | G → R in GSD1A. Ref.19 Ref.24 | VAR_009204 | |||||
| Natural variant | 83 | 1 | R → C in GSD1A; loss of catalytic activity. dbSNP rs1801175. Ref.8 Ref.9 Ref.10 Ref.12 Ref.14 Ref.17 Ref.18 Ref.21 Ref.22 Ref.24 Ref.25 | VAR_005239 | |||||
| Natural variant | 83 | 1 | R → H in GSD1A. dbSNP rs1801176. Ref.8 Ref.9 Ref.10 Ref.12 Ref.14 Ref.17 Ref.18 Ref.21 Ref.22 Ref.24 Ref.25 | VAR_005240 | |||||
| Natural variant | 83 | 1 | R → I in GSD1A. Ref.8 Ref.9 Ref.10 Ref.12 Ref.14 Ref.17 Ref.18 Ref.21 Ref.22 Ref.24 Ref.25 | VAR_005241 | |||||
| Natural variant | 108 | 1 | T → I in GSD1A. Ref.16 Ref.22 | VAR_009205 | |||||
| Natural variant | 110 | 1 | E → K in GSD1A. Ref.11 Ref.22 Ref.24 | VAR_005242 | |||||
| Natural variant | 111 | 1 | T → I in GSD1A. Ref.22 | VAR_046256 | |||||
| Natural variant | 113 | 1 | P → L in GSD1A. Ref.24 | VAR_046257 | |||||
| Natural variant | 116 | 1 | P → L in a breast cancer sample; somatic mutation. Ref.26 | VAR_035922 | |||||
| Natural variant | 119 | 1 | H → L in GSD1A. Ref.23 | VAR_046258 | |||||
| Natural variant | 122 | 1 | G → D in GSD1A. Ref.18 | VAR_046259 | |||||
| Natural variant | 124 | 1 | A → T in GSD1A. Ref.11 | VAR_005243 | |||||
| Natural variant | 156 | 1 | W → L in GSD1A. Ref.19 Ref.24 | VAR_009206 | |||||
| Natural variant | 166 | 1 | V → A in GSD1A. Ref.8 Ref.21 | VAR_046260 | |||||
| Natural variant | 166 | 1 | V → G in GSD1A. Ref.8 Ref.21 | VAR_005244 | |||||
| Natural variant | 170 | 1 | R → Q in GSD1A. Ref.12 Ref.24 | VAR_046261 | |||||
| Natural variant | 177 | 1 | F → C in GSD1A. Ref.24 | VAR_046262 | |||||
| Natural variant | 178 | 1 | P → S in GSD1A. Ref.24 | VAR_046263 | |||||
| Natural variant | 179 | 1 | H → P in GSD1A. Ref.18 | VAR_046264 | |||||
| Natural variant | 184 | 1 | G → E in GSD1A. Ref.11 Ref.17 Ref.22 | VAR_005245 | |||||
| Natural variant | 184 | 1 | G → V in GSD1A. Ref.11 Ref.17 Ref.22 | VAR_046265 | |||||
| Natural variant | 188 | 1 | G → D in GSD1A. Ref.11 Ref.19 Ref.21 Ref.22 Ref.24 | VAR_009207 | |||||
| Natural variant | 188 | 1 | G → R in GSD1A. Ref.11 Ref.19 Ref.21 Ref.22 Ref.24 | VAR_005246 | |||||
| Natural variant | 188 | 1 | G → S in GSD1A. Ref.11 Ref.19 Ref.21 Ref.22 Ref.24 | VAR_046266 | |||||
| Natural variant | 209 | 1 | Y → C in GSD1A; abolishes enzyme activity as well as reduces enzyme stability. Ref.25 | VAR_046268 | |||||
| Natural variant | 211 | 1 | L → P in GSD1A. Ref.11 | VAR_005247 | |||||
| Natural variant | 222 | 1 | G → R in GSD1A. Ref.17 | VAR_005248 | |||||
| Natural variant | 236 | 1 | W → R in GSD1A. Ref.24 | VAR_046269 | |||||
| Natural variant | 241 | 1 | A → T in GSD1A. Ref.22 | VAR_046270 | |||||
| Natural variant | 257 | 1 | P → L in GSD1A. Ref.18 | VAR_046271 | |||||
| Natural variant | 264 | 1 | N → K in GSD1A. Ref.14 | VAR_046272 | |||||
| Natural variant | 265 | 1 | L → P in GSD1A. Ref.24 | VAR_046273 | |||||
| Natural variant | 266 | 1 | G → V in GSD1A. Ref.15 | VAR_005249 | |||||
| Natural variant | 270 | 1 | G → R in GSD1A. Ref.12 Ref.17 Ref.22 Ref.24 | VAR_046274 | |||||
| Natural variant | 270 | 1 | G → V in GSD1A. Ref.12 Ref.17 Ref.22 Ref.24 | VAR_005250 | |||||
| Natural variant | 270 | 1 | G → W in GSD1A. Ref.12 Ref.17 Ref.22 Ref.24 | VAR_046275 | |||||
| Natural variant | 295 | 1 | R → C in GSD1A. Ref.17 Ref.21 | VAR_005251 | |||||
| Natural variant | 298 | 1 | S → P in GSD1A. Ref.17 | VAR_046276 | |||||
| Natural variant | 322 | 1 | F → L in GSD1A. Ref.22 | VAR_046277 | |||||
| Natural variant | 327 | 1 | Missing in GSD1A. Ref.22 Ref.24 | VAR_005252 | |||||
| Natural variant | 338 | 1 | V → F in GSD1A. Ref.15 Ref.17 Ref.22 | VAR_005253 | |||||
| Natural variant | 341 | 1 | I → N in GSD1A. Ref.10 | VAR_005254 | |||||
| Natural variant | 345 | 1 | L → R in GSD1A. Ref.24 | VAR_046278 | |||||
Experimental info | |||||||||
| Mutagenesis | 9 | 1 | H → A: Partial loss of catalytic activity. Ref.5 | ||||||
| Mutagenesis | 52 | 1 | H → A: Partial loss of catalytic activity. Ref.5 | ||||||
| Mutagenesis | 76 | 1 | K → N: Loss of catalytic activity. Ref.5 | ||||||
| Mutagenesis | 119 | 1 | H → A: Loss of catalytic activity. Ref.5 | ||||||
| Mutagenesis | 170 | 1 | R → Q: Loss of catalytic activity. Ref.5 | ||||||
| Mutagenesis | 176 | 1 | H → A: Loss of catalytic activity. Ref.5 | ||||||
| Mutagenesis | 179 | 1 | H → A: Loss of catalytic activity. Ref.5 | ||||||
| Mutagenesis | 197 | 1 | H → T: Partial loss of catalytic activity. Ref.5 | ||||||
| Mutagenesis | 252 | 1 | H → A: Partial loss of catalytic activity. Ref.5 | ||||||
| Mutagenesis | 307 | 1 | H → A: Partial loss of catalytic activity. Ref.5 | ||||||
| Mutagenesis | 353 | 1 | H → A: Partial loss of catalytic activity. Ref.5 | ||||||
| Sequence conflict | 192 | 1 | A → T in AAA16222. Ref.1 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a." Lei K.-J., Shelly L.L., Pan C.-J., Sidbury J.B., Chou J.Y. Science 262:580-583(1993) [PubMed: 8211187] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Liver. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Liver. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [4] | "Asparagine-linked oligosaccharides are localized to a luminal hydrophilic loop in human glucose-6-phosphatase." Pan C.J., Lei K.J., Chou J.Y. J. Biol. Chem. 273:21658-21662(1998) [PubMed: 9705299] [Abstract] Cited for: GLYCOSYLATION AT ASN-96. |
| [5] | "The catalytic center of glucose-6-phosphatase. HIS176 is the nucleophile forming the phosphohistidine-enzyme intermediate during catalysis." Ghosh A., Shieh J.-J., Pan C.-J., Sun M.-S., Chou J.Y. J. Biol. Chem. 277:32837-32842(2002) [PubMed: 12093795] [Abstract] Cited for: ACTIVE SITES, MUTAGENESIS OF HIS-9; HIS-52; LYS-76; HIS-119; ARG-170; HIS-176; HIS-179; HIS-197; HIS-252; HIS-307 AND HIS-353, CHARACTERIZATION OF VARIANT CYS-83. |
| [6] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed: 19159218] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-96, MASS SPECTROMETRY. Tissue: Liver. |
| [7] | "Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus." Lei K.-J., Chen Y.-T., Chen H., Wong L.-J.C., Liu J.-L., McConkie-Rosell A., van Hove J.L.K., Ou H.C.-Y., Yeh N.J., Pan L.Y., Chou J.Y. Am. J. Hum. Genet. 57:766-771(1995) [PubMed: 7573034] [Abstract] Cited for: VARIANTS GSD1A. |
| [8] | "Characterization of the mutations in the glucose-6-phosphatase gene in Israeli patients with glycogen storage disease type 1a: R83C in six Jews and a novel V166G mutation in a Muslim Arab." Parvari R., Moses S., Hershkovitz E., Carmi R., Bashan N. J. Inherit. Metab. Dis. 18:21-27(1995) [PubMed: 7623438] [Abstract] Cited for: VARIANTS GSD1A CYS-83 AND GLY-166. |
| [9] | "Glucose-6-phosphatase gene G327A mutation is common in Chinese patients with glycogen storage disease type Ia." Hwu W.-L., Chuang S.-C., Tsai L.-P., Chang M.-H., Chuang S.-M., Wang T.-R. Hum. Mol. Genet. 4:1095-1096(1995) [PubMed: 7655466] [Abstract] Cited for: VARIANT GSD1A ILE-83. |
| [10] | "Genetic analysis of the glucose-6-phosphatase mutation of type 1a glycogen storage disease in a Chinese family." Lee W.J., Lee H.M., Chi C.S., Shu S.G., Lin L.Y., Lin W.H. Clin. Genet. 50:206-211(1996) [PubMed: 9001800] [Abstract] Cited for: VARIANTS GSD1A HIS-83 AND ASN-341. |
| [11] | "Mutation analysis in 24 French patients with glycogen storage disease type 1a." Chevalier-Porst F., Bozon D., Bonardot A.-M., Bruni N., Mithieux G., Mathieu M., Maire I. J. Med. Genet. 33:358-360(1996) [PubMed: 8733042] [Abstract] Cited for: VARIANTS GSD1A VAL-38; ARG-77; LYS-110; THR-124; GLU-184; ARG-188 AND PRO-211. |
| [12] | "Molecular aspects of glycogen storage disease type Ia in Turkish patients: a novel mutation in the glucose-6-phosphatase gene." Huener G., Podskarbi T., Schuetz M., Baykal T., Sarbat G., Shin Y.S., Demirkol M. J. Inherit. Metab. Dis. 21:445-446(1998) [PubMed: 9700612] [Abstract] Cited for: VARIANTS GSD1A CYS-83; GLN-170 AND TRP-270. |
| [13] | "A novel mutation in a Brazilian patient with glycogen storage disease type 1a." Sartorato E.L., Reis F.C., Norato D.Y.J., Hackel C. J. Inherit. Metab. Dis. 21:447-447(1998) [PubMed: 9700613] [Abstract] Cited for: VARIANT GSD1A ARG-68. |
| [14] | "A new mutation of the glucose-6-phosphatase gene in a 4-year-old girl with oligosymptomatic glycogen storage disease type 1a." Keller K.M., Schuetz M., Podskarbi T., Bindl L., Lentze M.J., Shin Y.S. J. Pediatr. 132:360-361(1998) [PubMed: 9506659] [Abstract] Cited for: VARIANTS GSD1A CYS-83 AND LYS-264. |
| [15] | "Glycogen storage disease type Ia: four novel mutations (175delGG, R170X, G266V and V338F) identified." Rake J.P., ten Berge A.M., Verlind E., Visser G., Niezen-Koning K.E., Buys C.H.C.M., Smit G.P., Scheffer H. Hum. Mutat. 13:173-173(1999) [PubMed: 10094563] [Abstract] Cited for: VARIANTS GSD1A VAL-266 AND PHE-338. |
| [16] | "Identification of three novel mutations (Q54P, W70X and T108I) in the glucose-6-phosphatase gene of patients with glycogen storage disease type Ia." Trioche P., Francoual J., Chalas J., Capel L., Bernard O., Labrune P. Hum. Mutat. 14:91-91(1999) [PubMed: 10447271] [Abstract] Cited for: VARIANTS GSD1A PRO-54 AND ILE-108. |
| [17] | "Mutations in the glucose-6-phosphatase gene of 53 Italian patients with glycogen storage disease type Ia." Stroppiano M., Regis S., DiRocco M., Caroli F., Gandullia P., Gatti R. J. Inherit. Metab. Dis. 22:43-49(1999) [PubMed: 10070617] [Abstract] Cited for: VARIANTS GSD1A VAL-38; ARG-63; CYS-83; VAL-184; ARG-222; VAL-270; CYS-295; PRO-298 AND PHE-338. |
| [18] | "Glycogen storage disease type Ia: molecular diagnosis of 51 Japanese patients and characterization of splicing mutations by analysis of ectopically transcribed mRNA from lymphoblastoid cells." Akanuma J., Nishigaki T., Fujii K., Matsubara Y., Inui K., Takahashi K., Kure S., Suzuki Y., Ohura T., Miyabayashi S., Ogawa E., Iinuma K., Okada S., Narisawa K. Am. J. Med. Genet. 91:107-112(2000) [PubMed: 10748407] [Abstract] Cited for: VARIANTS GSD1A HIS-83; ASP-122; PRO-179 AND LEU-257. |
| [19] | "Molecular genetic analysis of 40 patients with glycogen storage disease type Ia: 100% mutation detection rate and 5 novel mutations." Seydewitz H.H., Matern D. Hum. Mutat. 15:115-116(2000) [PubMed: 10612834] [Abstract] Cited for: VARIANTS GSD1A ARG-20; ARG-81; LEU-156 AND ASP-188. |
| [20] | "Identification of a novel missense mutation (T16A) in the glucose-6-phosphatase gene in a Taiwan Chinese patient with glycogen storage disease Ia (von Gierke disease)." Wu M.-C., Tsai F.-J., Lee C.-C., Lin S.-P., Wu J.-Y. Hum. Mutat. 15:390-390(2000) [PubMed: 10738005] [Abstract] Cited for: VARIANT GSD1A ALA-16. |
| [21] | "Identification of mutations in the glucose-6-phosphatase gene in Czech and Slovak patients with glycogen storage disease type Ia, including novel mutations K76N, V166A and 540del5." Kozak L., Francova H., Hrabincova E., Stastna S., Peskova K., Elleder M. Hum. Mutat. 16:89-89(2000) [PubMed: 10874313] [Abstract] Cited for: VARIANTS GSD1A ASN-76; ARG-77; CYS-83; ALA-166; ARG-188 AND CYS-295. |
| [22] | "Genetic heterogeneity of glycogen storage disease type Ia in France: a study of 48 patients." Trioche P., Francoual J., Chalas J., Capel L., Lindenbaum A., Odievre M., Labrune P. Hum. Mutat. 16:444-444(2000) [PubMed: 11058903] [Abstract] Cited for: VARIANTS GSD1A ARG-5; VAL-38; PRO-54; CYS-83; ILE-108; LYS-110; ILE-111; GLU-184; ARG-188; THR-241; ARG-270; VAL-270; LEU-322; PHE-327 DEL AND PHE-338. |
| [23] | "A novel missense mutation (H119L) identified in a Taiwan Chinese family with glycogen storage disease Ia (von Gierke disease)." Wu M.-C., Tsai F.-J., Lee C.-C., Tsai C.-H., Wu J.-Y. Hum. Mutat. 16:447-447(2000) [PubMed: 11058910] [Abstract] Cited for: VARIANT GSD1A LEU-119. |
| [24] | "Glycogen storage disease type I: diagnosis and phenotype/genotype correlation." Matern D., Seydewitz H.H., Bali D., Lang C., Chen Y.-T. Eur. J. Pediatr. 161:S10-S19(2002) [PubMed: 12373566] [Abstract] Cited for: VARIANTS GSD1A ARG-20; VAL-38; PRO-65; ARG-68; ARG-77; ARG-81; CYS-83; HIS-83; LYS-110; LEU-113; LEU-156; GLN-170; CYS-177; SER-178; ARG-188; SER-188; ARG-236; PRO-265; VAL-270; PHE-327 DEL AND ARG-345. |
| [25] | "Glycogen storage disease type Ia in Argentina: two novel glucose-6-phosphatase mutations affecting protein stability." Angaroni C.J., de Kremer R.D., Argarana C.E., Paschini-Capra A.E., Giner-Ayala A.N., Pezza R.J., Pan C.-J., Chou J.Y. Mol. Genet. Metab. 83:276-279(2004) [PubMed: 15542400] [Abstract] Cited for: VARIANTS GSD1A ARG-16; PRO-54; CYS-83 AND CYS-209, CHARACTERIZATION OF VARIANTS GSD1A ARG-16 AND CYS-209. |
| [26] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed: 16959974] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] LEU-116. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| U01120 mRNA. Translation: AAA16222.1. AK313982 mRNA. Translation: BAG36695.1. BC130478 mRNA. Translation: AAI30479.1. BC136369 mRNA. Translation: AAI36370.1. | |
| IPI | IPI00019500. |
| PIR | A48251. |
| RefSeq | NP_000142.1. |
| UniGene | Hs.212293 Hs.714887 |
3D structure databases | |
| ModBase | Search... |
Genome annotation databases | |
| Ensembl | ENSG00000131482. Homo sapiens. [Contig view] |
| GeneID | 2538. |
| KEGG | hsa:2538. |
| UCSC | uc002icb.1. human. |
Organism-specific databases | |
| GeneCards | GC17P038306. |
| H-InvDB | HIX0039254. |
| HGNC | HGNC:4056. G6PC. |
| MIM | 232200. gene+phenotype. |
| Orphanet | 364. Glycogen storage disease type 1. |
| PharmGKB | PA28468. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOGENOM | P35575. |
| HOVERGEN | P35575. |
| OMA | P35575. FYLLLKG. |
Enzyme and pathway databases | |
| BioCyc | MetaCyc:MON-13536. |
| BRENDA | 3.1.3.9. 247. |
| Pathway_Interaction_DB | hnf3bpathway. FOXA2 and FOXA3 transcription factor networks. foxopathway. FoxO family signaling. |
| Reactome | REACT_474. Metabolism of carbohydrates. |
Gene expression databases | |
| ArrayExpress | P35575. |
| Bgee | P35575. |
| CleanEx | HS_G6PC. |
| GermOnline | ENSG00000131482. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR016275. Glucose-6-phosphatase. IPR000326. P_Acid_Pase_2/haloperoxidase. [Graphical view] |
| Pfam | PF01569. PAP2. 1 hit. [Graphical view] |
| PIRSF | PIRSF000905. Glucose-6-phosphatase. 1 hit. |
| SMART | SM00014. acidPPc. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 10017. |
| SOURCE | Search... |
Entry information
| Entry name | G6PC_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P35575 Secondary accession number(s): A1L4C0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| SIMILARITY comments Index of protein domains and families |

Clusters with


